BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29753117)

  • 41. The selective dopamine D₃ receptor antagonist SB-277011-A significantly decreases binge-like consumption of ethanol in C57BL/J6 mice.
    Rice OV; Schonhar CA; Gaál J; Gardner EL; Ashby CR
    Synapse; 2015 Jun; 69(6):295-8. PubMed ID: 25764479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alcohol alters the activation of ERK1/2, a functional regulator of binge alcohol drinking in adult C57BL/6J mice.
    Agoglia AE; Sharko AC; Psilos KE; Holstein SE; Reid GT; Hodge CW
    Alcohol Clin Exp Res; 2015 Mar; 39(3):463-75. PubMed ID: 25703719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.
    Pastor M; Fernández-Calle R; Di Geronimo B; Vicente-Rodríguez M; Zapico JM; Gramage E; Coderch C; Pérez-García C; Lasek AW; Puchades-Carrasco L; Pineda-Lucena A; de Pascual-Teresa B; Herradón G; Ramos A
    Eur J Med Chem; 2018 Jan; 144():318-329. PubMed ID: 29275231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dependence-induced ethanol drinking and GABA neurotransmission are altered in Alk deficient mice.
    Schweitzer P; Cates-Gatto C; Varodayan FP; Nadav T; Roberto M; Lasek AW; Roberts AJ
    Neuropharmacology; 2016 Aug; 107():1-8. PubMed ID: 26946429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice.
    Kasten CR; Boehm SL
    Behav Brain Res; 2014 Oct; 272():238-47. PubMed ID: 25026094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence.
    Carvajal F; Alcaraz-Iborra M; Lerma-Cabrera JM; Valor LM; de la Fuente L; Sanchez-Amate Mdel C; Cubero I
    Behav Brain Res; 2015; 287():230-7. PubMed ID: 25827928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous pleiotrophin and midkine regulate LPS-induced glial responses.
    Fernández-Calle R; Vicente-Rodríguez M; Gramage E; de la Torre-Ortiz C; Pérez-García C; Ramos MP; Herradón G
    Neurosci Lett; 2018 Jan; 662():213-218. PubMed ID: 29061398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers.
    Yamakawa T; Kurosawa N; Kadomatsu K; Matsui T; Itoh K; Maeda N; Noda M; Muramatsu T
    Cancer Lett; 1999 Jan; 135(1):91-6. PubMed ID: 10077226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine.
    Gramage E; Martín YB; Ramanah P; Pérez-García C; Herradón G
    Neuroscience; 2011 Sep; 190():307-17. PubMed ID: 21704677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ.
    Diamantopoulou Z; Bermek O; Polykratis A; Hamma-Kourbali Y; Delbé J; Courty J; Katsoris P
    Mol Cancer; 2010 Aug; 9():224. PubMed ID: 20738847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleiotrophin differentially regulates the rewarding and sedative effects of ethanol.
    Vicente-Rodríguez M; Pérez-García C; Ferrer-Alcón M; Uribarri M; Sánchez-Alonso MG; Ramos MP; Herradón G
    J Neurochem; 2014 Dec; 131(5):688-95. PubMed ID: 25073406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blocking receptor protein tyrosine phosphatase beta/zeta: a potential therapeutic strategy for Parkinson's disease.
    Herradón G; Ezquerra L
    Curr Med Chem; 2009; 16(25):3322-9. PubMed ID: 19548869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic inactivation of midkine modulates behavioural responses to ethanol possibly by enhancing GABA(A) receptor sensitivity to GABA(A) acting drugs.
    Vicente-Rodríguez M; Pérez-García C; Haro M; Ramos MP; Herradón G
    Behav Brain Res; 2014 Nov; 274():258-63. PubMed ID: 25149366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
    Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE
    Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta.
    Maeda N; Ichihara-Tanaka K; Kimura T; Kadomatsu K; Muramatsu T; Noda M
    J Biol Chem; 1999 Apr; 274(18):12474-9. PubMed ID: 10212223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.
    Polytarchou C; Hatziapostolou M; Poimenidi E; Mikelis C; Papadopoulou A; Parthymou A; Papadimitriou E
    Int J Cancer; 2009 Apr; 124(8):1785-93. PubMed ID: 19058221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding.
    Abbott KL; Matthews RT; Pierce M
    J Biol Chem; 2008 Nov; 283(48):33026-35. PubMed ID: 18838383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Receptor type protein tyrosine phosphatase zeta-pleiotrophin signaling controls endocytic trafficking of DNER that regulates neuritogenesis.
    Fukazawa N; Yokoyama S; Eiraku M; Kengaku M; Maeda N
    Mol Cell Biol; 2008 Jul; 28(14):4494-506. PubMed ID: 18474614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binge-like ethanol drinking activates anaplastic lymphoma kinase signaling and increases the expression of STAT3 target genes in the mouse hippocampus and prefrontal cortex.
    Hamada K; Ferguson LB; Mayfield RD; Krishnan HR; Maienschein-Cline M; Lasek AW
    Genes Brain Behav; 2021 Feb; ():e12729. PubMed ID: 33641239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice.
    Bahi A; Sadek B; Nurulain SM; Łażewska D; Kieć-Kononowicz K
    Physiol Behav; 2015 Nov; 151():189-97. PubMed ID: 26169446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.